Brand Name: Diflucan Generic Name: Fluconazole Drug Classification: Antibiotics (antifungal)

  • June 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Brand Name: Diflucan Generic Name: Fluconazole Drug Classification: Antibiotics (antifungal) as PDF for free.

More details

  • Words: 376
  • Pages: 2
Brand name: Diflucan Generic name: Fluconazole Drug Classification: Antibiotics (Antifungal) Indication: Adult: Oral or vaginal candidiasis unresponsive to nystatin or clotrimazole; nonlifethreatening Candida infections (cystitis, esophaglitis); treatment of hepatosplenic candidiasis and other Candida infections in person unable to tolerate amphotericin B; treatment of cryptococcal infections; secondary prophylaxis in allogeneic bone marrow transplant recipients. Mechanism of action: Interferes with cytochrome P-450 activity, decreasing ergosterol synthesis (principal sterol in fungal cell membrane) and inhibiting cell membrane formation. Dose: Adult Candidiasis, disseminated candidiasis & other invasive candidal infection 400 mg on the 1 st day followed by 200 mg daily. Vaginal candidiasis150 mg as single oral dose. Oropharyngealcandidiasis 50 mg once daily for 7-14 days. If necessary, continue treatment for longer periods in patients w/ severely compromised immune function. Candidal infection of mucosa 50 mg daily for 14- 30 days, may be increased up to 100 mg daily. Children mucosal candidiasis 3 mg/kg. Systemic candidiasis 6-12 mg/kg daily. Prevention of candidiasis based on risk o developing fungal infections 50-400 mg once daily. Deep endemic mycoses200-400 mg daily for up to 2 yr. Cryptococcal meningitis & cryptococcal infections at other sites 400 mg on the 1st day followed by 200- 400 once daily for atleast 6-8 wk. Prevention of relapse of cryptococcal meningitis in patients w/ AIDS 200 mg daily after a full course of primary therapy. Atrophic oral candidiasis associated with dentures 50 mg once daily for 14 days concurrently w/ local antiseptic measures to the denture. Dermal infection including tinea

pedis, corporis, cruris & candida infections 150 mg once wkly or 50 mg once daily for 2-4 wk (tinea pedis: up to 6 wk). Tinea vesicolor 50 mg once daily for 2-4 wk. Contraindication: Known hypersensitivity to fluconazole or other azoles; concomitant administration with terfenadine. Special Precaution: Pregnancy, lactation Adverse Reactions: CNS: headache GI: hepatotoxicity, abdominal discomfort, diarrhea, nausea, vomiting Derm: exfoliative skin disorder including Stevens - Johnson syndrome. Drug Interaction: Warfarin, oral sulfonylureas, phenytoin, rifampicin, cyclosporin, theophylline, terfenadine, zidovudine, OC. Form: Capsule- 50mg, 150mg, 200mg; vial- 2mg/mL Pregnancy Risk Category: C Nursing Responsibilities:  Assess infected area and monitor CSF cultures before and periodically during therapy.  Monitor BUN and serum creatinine before and periodically during therapy.  Monitor liver function tests before and periodically during therapy.

Related Documents